Doctor Mauro Feola
Cardiology Department, Mondovi (Italy)
Impact of SGLT2i on CV mortality and SCD
Event: Heart Failure 2024
Topic: Ventricular Remodelling
Session: Guideline recommended medical therapy - implications of current publications and guidelines for daily clinical practice
Empaglifozin modifies the arterial stiffness in type-2 diabetic patients: a preliminary report
Event: Heart Failure 2024
Topic: Antidiabetic Pharmacotherapy
Session: Pharmacology and pharmacotherapy
Predicting cardiovascular events in out-of-hospital patients presenting with atypical chest pain and complete left bundle branch block: role of cta and echocardiographic global longitudinal strain.
Event: Heart Failure 2024
Topic: Imaging
Session: ePosters in chronic heart failure - diagnostic methods
Arterial stiffness in heart failure patients after an acute episode of acute decompensation : preliminary results
Event: Heart Failure 2019
Topic: Pathophysiology and Mechanisms
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
The role of Response-to-Diuretic in predicting prognosis in discharged heart failure patients after an acute decompensation.
Event: Heart Failure 2018
Topic: Cardiotoxicity of Drugs and Other Therapies
Session: Chronic Heart Failure – Pathophysiology and Mechanisms
The predictive value of plasma biomarkers in heart failure patients: do they maintain their value in elderly population?
Event: Heart Failure 2018
Topic: Biomarkers
Session: Acute Heart Failure – Diagnostic Methods
The prognostic value of different allelic distribution of aldosterone synthase receptor in a congestive heart failure caucasian population.
Event: HEART FAILURE 2016
Topic: Molecular biology / genetics
Session: Basic Science: Molecular biology / Genetics
Role of galectin-3 and plasma Btype-natriuretic peptide in predicting prognosis in discharged heart failure patients
Event: HEART FAILURE 2016
Topic: Prognosis (using biomarkers)
Session: Basic Science: Biomarkers
